Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    11707753 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Preventing Tolerance to Oxymetazoline in Allergic Rhinitis
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: oxymetazoline-fluticasone propionate;   Drug: Oxymetazoline
2 Withdrawn Azelastine Fluticasone Combination vs. Fluticasone
Condition: Allergic Rhinitis
Interventions: Drug: Azelastine , fluticasone;   Drug: Fluticasone propionate
3 Completed Differential Adrenoreceptor Mediated Tachyphylaxis and Upregulation
Conditions: Allergic Rhinitis;   Tachyphylaxis;   Rhinitis Medicamentosa
Interventions: Drug: Oxymetazoline 0.05% w/v;   Drug: Fluticasone propionate 50 micrograms per actuation;   Drug: Prazosin hydrochloride;   Drug: Placebo to Prazosin
4 Completed To Evaluate Adenosine Monophosphate and Allergen Challenge in Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: levocetirizine;   Drug: placebo to levocetirizine

Study has passed its completion date and status has not been verified in more than two years.